Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma.

@article{Park2014StimulatedST,
  title={Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma.},
  author={Hee Jeong Park and Geum-Cheol Jeong and Seong Young Kwon and Jung-joon Min and Hee-Seung Bom and Ki Ho Park and Sang-Geon Cho and Sae-Ryung Kang and Jahae Kim and Ho-Chun Song and Ari Chong and Su Woong Yoo},
  journal={Nuclear medicine and molecular imaging},
  year={2014},
  volume={48 4},
  pages={255-61}
}
PURPOSE To investigate the clinical importance of serum thyroglobulin (Tg) levels just before high-dose I-131 ablation therapy (preablation Tg) for predicting therapeutic failure in patients with papillary thyroid carcinoma (PTC). METHODS Patients with PTC (n = 132) undergoing total thyroidectomy followed by the first high-dose I-131 ablation therapy (HI-Rx) were included in this retrospective review. Just before HI-Rx, preablation Tg, anti-Tg antibody, and TSH were measured. The patients… CONTINUE READING